SCHEMBL19203353

SCHEMBL19203353

Cc1ccc2c(C(=O)O)c(O)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.52
LDHA P00338 3/20 0.51
LDHB P07195 3/20 0.51
ALB P02768 1/20 0.47
MPL P40238 2/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP1A2 P05177 2/20 0.44
MEN1 O00255 1/20 0.44
GLA P06280 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
DHODH Q02127 2/20 0.43
MCL1 Q07820 1/20 0.42
TRPA1 O75762 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
LCK P06239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19201822 0.87 CSNK2A1 (0.53) CSNK2A1LDHALDHBALBMPL
SCHEMBL931068 0.84 ALDH1A1 (0.52) CSNK2A1LDHALDHBALBMPL
SCHEMBL9551152 0.83 ERN1 (0.50) LDHALDHBCYP1A2CYP2C19LCK
SCHEMBL10111010 0.82 CYP1A2 (0.53) CSNK2A1LDHALDHBALBMPL
SCHEMBL30623601 0.82 ALDH1A1 (0.47) CSNK2A1LDHALDHBALBMPL
SCHEMBL30178354 0.81 CA12 (0.48) MPLKDM4EALDH1A1HPGDHSD17B10
SCHEMBL732139 0.81 CA12 (0.48) MPLKDM4EALDH1A1HPGDHSD17B10
SCHEMBL25487733 0.81 LDHA (0.46) CSNK2A1LDHALDHBALBMPL
Ethylene SCHEMBL28494344 0.81 ALDH1A1 (0.49) CSNK2A1LDHALDHBALBMPL
SCHEMBL19202293 0.81 LDHA (0.58) CSNK2A1LDHALDHBALBMPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023287067-A1 ANTIBACTERIAL COMPOUND 주식회사 엘지화학 2023-01-19 WO disclosed
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ORMCO CORPORATION 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE SP1, GPER1, GRIN1 CSNK2A1 3350/4885LDHA 2656/4885LDHB 2298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.